These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 25422661)

  • 21. Topical 5% tranexamic acid for the treatment of melasma in Asians: a double-blind randomized controlled clinical trial.
    Kanechorn Na Ayuthaya P; Niumphradit N; Manosroi A; Nakakes A
    J Cosmet Laser Ther; 2012 Jun; 14(3):150-4. PubMed ID: 22506692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of therapeutic effects of conventional and liposomal form of 4% topical hydroquinone in patients with melasma.
    Taghavi F; Banihashemi M; Zabolinejad N; Salehi M; Jaafari MR; Marhamati H; Golnouri F; Dorri M
    J Cosmet Dermatol; 2019 Jun; 18(3):870-873. PubMed ID: 30105847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of tranexamic acid 5% cream vs hydroquinone 4% cream in treating melasma: A split-face comparative clinical, histopathological, and antera 3D camera study.
    El-Husseiny R; Rakha N; Sallam M
    Dermatol Ther; 2020 Nov; 33(6):e14240. PubMed ID: 32856757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of the combination of tranexamic acid injection and electro-optical synergy (ELOS) versus tranexamic acid injection alone in the treatment of melasma.
    Wang Y; Tang L; Duan J; Wang L; Ye F
    Lasers Med Sci; 2023 Aug; 38(1):179. PubMed ID: 37552377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effectiveness and safety of 3% tranexamic acid cream vs. 4% hydroquinone cream for mixed-type melasma in skin of color: a double-blind, split-face, randomized controlled trial.
    Yasnova N; Sirait SP; Rahmayunita G
    Acta Dermatovenerol Alp Pannonica Adriat; 2024 Jun; 33(2):83-88. PubMed ID: 38918942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study of oral tranexamic acid, topical tranexamic acid, and modified Kligman's regimen in treatment of melasma.
    Sahu PJ; Singh AL; Kulkarni S; Madke B; Saoji V; Jawade S
    J Cosmet Dermatol; 2020 Jun; 19(6):1456-1462. PubMed ID: 32346962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparing the efficacy of Myjet-assisted tranexamic acid and vitamin C in treating melasma: A split-face controlled trial.
    Zhao H; Li M; Zhang X; Li L; Yan Y; Wang B
    J Cosmet Dermatol; 2020 Jan; 19(1):47-54. PubMed ID: 31479196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy and safety of topical 5% methimazole vs 4% hydroquinone in the treatment of melasma: A randomized controlled trial.
    Gheisari M; Dadkhahfar S; Olamaei E; Moghimi HR; Niknejad N; Najar Nobari N
    J Cosmet Dermatol; 2020 Jan; 19(1):167-172. PubMed ID: 31102345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination of Plasma Rich in Growth Factors With Topical 4% Hydroquinone Compared With Topical 4% Hydroquinone Alone in the Treatment of Dermal Type of Melasma: A Single-Blinded Randomized Split-Face Study.
    Amiri R; Karimi Maskooni M; Farsinejad A; Karvar M; Khalili M; Aflatoonian M
    Indian Dermatol Online J; 2024; 15(4):593-598. PubMed ID: 39050052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical 3% tranexamic acid enhances the efficacy of 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser in the treatment of melasma.
    Laothaworn V; Juntongjin P
    J Cosmet Laser Ther; 2018 Oct; 20(6):320-325. PubMed ID: 29461121
    [No Abstract]   [Full Text] [Related]  

  • 31. Randomized, double-blind, placebo-controlled split-face trial of the efficacy of tranexamic acid by drug delivery through microneedling in the treatment of melasma.
    Kuster Kaminski Arida D; Orso Rebellato PR; Marioto de Campos GL; Costa A; Vilaverde Schmitt J; Larocca Skare T; Rodrigues Lisboa Faucz L
    J Cosmet Dermatol; 2021 Dec; 20(12):4005-4010. PubMed ID: 34077619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy in treatment of facial melasma with thulium 1927-nm fractional laser-assisted topical tranexamic acid delivery: a split-face, double-blind, randomized controlled pilot study.
    Wanitphakdeedecha R; Sy-Alvarado F; Patthamalai P; Techapichetvanich T; Eimpunth S; Manuskiatti W
    Lasers Med Sci; 2020 Dec; 35(9):2015-2021. PubMed ID: 32506227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A split face comparative study between intradermal tranexamic acid and Erbium-YAG laser in treatment of melasma.
    Otb S; Shaarawy E; Sadek A; Abdallah N; Agamia N; Soliman M; Tawfik AA
    J Dermatolog Treat; 2022 Feb; 33(1):555-559. PubMed ID: 32420770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of 755-nm alexandrite picosecond laser in melasma management.
    Pulumati A; Jaalouk D; Algarin YA; Nouri K
    Arch Dermatol Res; 2023 Dec; 316(1):60. PubMed ID: 38151661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Randomized, Double-Blind, Split-Face Study of Topical Silymarin vs 2% Hydroquinone Cream in Melasmas.
    Wattanakrai P; Nimmannitya K
    J Drugs Dermatol; 2022 Dec; 21(12):1304-1310. PubMed ID: 36468967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Efficacy of Topical Tranexamic Acid With Microneedling in Melasma.
    Kaur A; Bhalla M; Pal Thami G; Sandhu J
    Dermatol Surg; 2020 Nov; 46(11):e96-e101. PubMed ID: 32769524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination of autologous platelet rich plasma and hydroquinone 4% is more effective than hydroquinone alone in treatment of melasma: A split-face comparative study.
    Tekam PS; Belgaumkar VA
    Dermatol Ther; 2022 Nov; 35(11):e15761. PubMed ID: 36068674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination Topical Tranexamic Acid and Vitamin C for the Treatment of Refractory Melasma.
    Kaikati J; El Bcherawi N; Khater JA; Dib SM; Kechichian E; Helou J
    J Clin Aesthet Dermatol; 2023 Jul; 16(7):63-65. PubMed ID: 37560507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficacy and safety of microneedling with topical tranexamic acid for melasma treatment: A systematic review and meta-analysis.
    Feng X; Su H; Xie J
    J Cosmet Dermatol; 2024 Jan; 23(1):33-43. PubMed ID: 37584240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topical 5% tranexamic acid with 30% glycolic acid peel: An useful combination for accelerating the improvement in melasma.
    Sahu P; Dayal S; Bhardwaj N
    Dermatol Ther; 2021 Nov; 34(6):e15107. PubMed ID: 34423510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.